Results per Page:
Cell biologist and former Fred Hutch division leader Dr. Jonathan Cooper retires
Cooper sustained the distinct culture of Basic Sciences for four decades
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
March 26, 2025
Ancient heritage discovered for a family of antiviral proteins
From the Emerman and Malik Labs, Basic Sciences and Human Biology Divisions
Evolutionary cell biologist Dr. Grant King named a Hanna Gray Fellow
Long fascinated by life seen and unseen, King awarded eight years of funding to finish postdoctoral training at Fred Hutch and establish an independent lab
Bottleneck breakthrough
Fred Hutch researchers discover why some HIV-1 variants are more transmissible than others, which could generate new approaches to stop the virus that causes AIDS at cell entry
Finding the golden ticket? Cyclin T1 is required for HIV-1 latency reactivation
From the Emerman lab, Human Biology and Basic Sciences Divisions
Trimming the unknowns: identifying the function of primate TRIM34
From the Ohainle and Emerman labs, Human Biology and Basic Sciences Divisions
Panning for gold in a dependent-sea of genes
From the Emerman Lab, Human Biology and Basic Sciences Divisions
For the first time (in cryo-EM): A3G and Vif structure revealed
From the Emerman lab, Human Biology and Basic Sciences Divisions
A human-specific motif facilitates CARD8 inflammasome activation after HIV-1 infection
From the Emerman and Mitchell labs, Cancer Basic Biology Programs, Cancer Consortium and UW Microbiology.
License to Kill: Latency HIV-CRISPR pinpoints how to blow latent HIV’s cover
From the Emerman and Henikoff Labs, Pathogen Associated Malignancies and Cancer Basic Biology Programs, Cancer Consortium.
A Passport to Cross-species Transmission
From the Emerman Lab, Human Biology Division
AIDS@40: Stories of hope and heroes
The people and the science devoted to stopping HIV
No ‘black diamond’ ski slopes for the TRIM5α antiviral protein
From the Malik and Emerman labs, Basic Sciences Division
A3C tandem domain proteins have increased anti-HIV-1 activity and are resistant to antagonism by HIV-1 Vif
From the Emerman laboratory, Human Biology Division
TRIMs attack: TRIM34 and TRIM5alpha work together to block HIV-1 infection
From the Emerman laboratory, Human Biology and Basic Sciences Divisions
Pushing science forward while working from home
As COVID-19 forces research labs to drastically reduce on-site operations, scientists figure out how to advance their work and stay connected
A short primer on coronavirus biology
Hutch virologist explains viral pandemics and COVID-19
What's with the spikes?
Those structures that give coronavirus its name might be SARS-CoV-2’s weak point
Dr. Michael Emerman to give Bernard Fields lecture at CROI
Talk will cover how lessons from HIV’s evolutionary past could lead to new therapies, cure
Age-old arms race points way to new-and-improved antiviral protein
Guided by evolution, scientists create more potent antiviral that unexpectedly continues blocking dissimilar viruses